BMO Capital Maintains Outperform on Chemours, Lowers Price Target to $39

Chemours Co. +5.64% Pre

Chemours Co.

CC

20.78

20.78

+5.64%

0.00% Pre

BMO Capital analyst John McNulty maintains Chemours (NYSE: CC) with a Outperform and lowers the price target from $45 to $39.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via